Industry Leader

The Insurance Implications Of Global Clinical Trials

Global clinical trials will only continue to grow in importance because of the need to develop additional treatments and therapies, but this accelerated growth pace alongside a myriad of regulatory pressures means that having a dedicated risk and insurance strategy has never been more important for life sciences companies.

Addressing Health Inequities With RWE: Not Just Lip Service

The relative paucity of population-specific clinical data highlights the importance of real-world evidence (RWE) as a means to more fully characterize the impact of medications on minority populations in the community setting.

Supply Chain Problems: Overcoming The Challenges

Life science supply chains are highly complex and need to take into consideration IP, changing tax and market needs, growing reliance on third-party partners, and more. This all requires vigilant governance and risk management.

How Do I Participate In The Legislative Process?

As an entrepreneur, day-to-day management, financing, and growth are critical aspects of the job. For those who also lean toward service, there’s an opportunity to extend beyond these daily concerns and think through a national approach.

How Cell And Gene Therapies Are Advancing Collaborations In Biopharma

The last time I wrote for Life Science Leader, I highlighted the importance of collaboration in the field of regenerative medicine. Here, I wanted to reassess how these collaborations are elevating the state of science as well as diversity initiatives with a focus on cell and gene therapies.

The Future Of Pharma Lies In Gaming Technologies

Pharma is seeing significant benefits (e.g., shortened time-to-market) from tools such as augmented reality (AR), mixed reality (MR), virtual reality (VR), and extended reality (XR) technologies when applied to clinical trials, R&D, and manufacturing.

Can AI/ML Help Solve Sex Bias In Clinical Trials?

To assess medicines for safety and efficacy it is important that clinical trials are representative of biological sex. Too often, though, women are underrepresented in clinical trials.

5 Life Science Trends To Watch

During the pandemic, clinical trials were impacted as people avoided unnecessary interactions with healthcare. As the nation continues to adjust, here are five trends that will change the way medical solutions are developed and administered.

A Nigerian Student’s Striking Pictures Illustrate Lessons We All Must Learn

Academia and industry must transform how we see skin — and how the medical field represents diverse identities.

How We Collaborated With The FDA For Clinical Trial Success

To overcome the unique challenges associated with conducting rare disease clinical trials, Timber Pharmaceuticals began formal discussions with the FDA early on.